Chennai Meenakshi Multispecialit (BSE: 523489) is a Chennai, Tamil Nadu-based company in the Hospitals and Healthcare Centers industry. With a market capitalisation of ₹26 Cr, it ranks #4,256 by market cap among the 6,197 Indian listed companies on FinBizNet, and #40 of 46 in Hospitals and Healthcare Centers. At ₹36.00 (as of 16 Nov 2026), the share price is 30.6% below its 52-week high of ₹51.86 and 14.2% above its 52-week low of ₹31.51. The share price is down 28.4% over one year and down 5.7% over three months.
| Current Price | ₹36.00 |
|---|---|
| Market Cap | ₹26 Cr |
| BSE Code | 523489 |
| Sector | Health Care > Health Care Equipment and Services > Health Care Providers and Services |
| Sub-Industry | Health Care Facilities > Hospitals and Healthcare Centers |
| P/E Ratio | Not meaningful (loss) |
| Return on Equity | 45.02% |
| Return on Assets | -3.06% |
| 52-Week Range | ₹31.51 – ₹51.86 |
| 1-Year Price Change | -28.4% |
| 3-Month Price Change | -5.7% |
| Beta (1Y) | 0.39 |
| Headquarters | Chennai, Tamil Nadu |
| Website | www.cmmh.in |
| Revenue | ₹9 Cr |
|---|---|
| Net Profit | ₹0 Cr |
| Net Margin | 0.0% |
| EPS (Basic) | ₹0.00 |
| Basis | standalone |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Chennai Meenakshi Multispecialit reported revenue of ₹9 Cr in Q1 FY27, down 0.7% from ₹9 Cr in Q1 FY26 and down 12.4% from ₹10 Cr in Q4 FY26. It posted a net profit of ₹0 Cr for the quarter, against a net loss of ₹1 Cr in Q1 FY26. Across the 8 quarters from Q2 FY25 to Q1 FY27, quarterly revenue ranged from ₹8 Cr (Q2 FY25) to ₹10 Cr (Q4 FY26). The company reported a net loss in 5 of these 8 quarters.
| Quarter | Revenue | Net Profit | Net Margin |
|---|---|---|---|
| Q1 FY27 | ₹9 Cr | ₹0 Cr | 0.0% |
| Q4 FY26 | ₹10 Cr | −₹0 Cr | −0.2% |
| Q3 FY26 | ₹9 Cr | −₹1 Cr | −5.9% |
| Q2 FY26 | ₹9 Cr | ₹0 Cr | 1.6% |
| Q1 FY26 | ₹9 Cr | −₹1 Cr | −8.6% |
| Q4 FY25 | ₹9 Cr | ₹0 Cr | 3.4% |
| Q3 FY25 | ₹9 Cr | −₹1 Cr | −7.1% |
| Q2 FY25 | ₹8 Cr | −₹1 Cr | −8.3% |
Standalone figures (₹ crore, XBRL filings).
Promoters held 67.29% of Chennai Meenakshi Multispecialit's shares as of Mar 2026, unchanged from Mar 2025. Delivery averaged 86.9% of traded volume across 15 BSE sessions (21 Oct 2026 – 13 Nov 2026).
Chennai Meenakshi Multispeciality Hospital Limited operates a multi-specialty hospital in Chennai, India. It also sells pharmacy products. The company was formerly known as Devaki Hospital Limited and changed its name to Chennai Meenakshi Multispeciality Hospital Limited in November 2007. Chennai Meenakshi Multispeciality Hospital Limited was incorporated in 1990 and is based in Chennai, India.
1. Hospital-This segment operates a hospital. It offers services in the areas of cardiology, cosmetic and plastic surgery, diabetology, endocrinology, dermatology, dentistry, ENT, surgical gastroenterology, general surgery, and gynecology.
1. Healthcare Services-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Apollo Hospitals Enterprise Limited | ₹1,23,712 Cr | 63 | 21.50% | ₹7,615 Cr | +11.6% |
| Max Healthcare Institute Ltd | ₹91,978 Cr | 63.9 | 14.33% | ₹2,569 Cr | -16.6% |
| Manipal Health Enterprises Ltd | ₹89,110 Cr | 88.4 | — | ₹3,399 Cr | — |
| Aster Dm Healthcare Limited (Asterdm) | ₹63,041 Cr | 97.6 | 10.07% | ₹2,829 Cr | +4.3% |
| Fortis Healthcare Ltd. | ₹58,283 Cr | 55.1 | 11.01% | ₹2,735 Cr | -25.1% |
| Global Health Ltd (Medanta) | ₹38,422 Cr | 69.7 | 15.03% | ₹1,469 Cr | +16.2% |
| Narayana Hrudayalaya Limited | ₹37,907 Cr | 46.2 | 19.85% | ₹2,844 Cr | +2.8% |
| Krishna Institute Of Medical Science (KIMS) | ₹29,056 Cr | 120.6 | 9.72% | ₹1,344 Cr | +0.2% |
| Chennai Meenakshi Multispecialit | ₹26 Cr | n/m | 45.02% | ₹9 Cr | -28.4% |
Listed by market capitalisation. Ratios are shown for context only.
Chennai Meenakshi Multispecialit is trading at ₹36.00, with a market capitalisation of ₹26 Cr.
Chennai Meenakshi Multispecialit operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Facilities > Hospitals and Healthcare Centers).
Chennai Meenakshi Multispecialit has a return on equity of 45.02%.
Chennai Meenakshi Multispecialit is listed on the BSE under the scrip code 523489.
Chennai Meenakshi Multispecialit's share price is down 28.4% over one year and down 5.7% over three months. Its 52-week range is ₹31.51 to ₹51.86.
In Q1 FY27, Chennai Meenakshi Multispecialit reported revenue of ₹9 Cr and net profit of ₹0 Cr, with basic EPS of ₹0 (standalone, parsed from the company's exchange filing).
Chennai Meenakshi Multispecialit reported revenue of ₹9 Cr in Q1 FY27, down 0.7% from ₹9 Cr in Q1 FY26 and down 12.4% from ₹10 Cr in Q4 FY26.
Promoters held 67.29% of Chennai Meenakshi Multispecialit's shares as of Mar 2026, unchanged from Mar 2025.
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.